OKLAHOMA CITY — An innovative new fertility preservation option offered at OU Health is giving new hope to patients who face medical treatments that are likely to impair their ability
Business supports Stephenson Cancer Center | The Journal Record journalrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalrecord.com Daily Mail and Mail on Sunday newspapers.
OU Health researchers receive millions in grants to study endometrial cancer kosu.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kosu.org Daily Mail and Mail on Sunday newspapers.
OU Health researchers receive millions in grants to study endometrial cancer kgou.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kgou.org Daily Mail and Mail on Sunday newspapers.
Kathleen N. Moore, MD, MS, expands on the importance of continuing to investigate PARP inhibitors in ovarian cancer and highlights key updates to have come out of the 2023 ESMO Congress
Bartlesville Radio » News » Cherokee Nation Using Funds to Treat Cancer bartlesvilleradio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bartlesvilleradio.com Daily Mail and Mail on Sunday newspapers.
OU Health Earns Grant for Endometrial Cancer Research miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Bartlesville Radio » News » Cherokee Nation Using Funds to Treat Cancer bartlesvilleradio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bartlesvilleradio.com Daily Mail and Mail on Sunday newspapers.
A recent study showed that incorporating immunotherapy checkpoint blockade into treatment before and after surgery can increase treatment-related side effects.
Kathleen N. Moore, MD, MS, discusses the challenges with utilizing immune-targeted therapy for ovarian cancer, expands on the impact of the tumor microenvironment on the effectiveness of immune checkpoint inhibitors, and details ongoing research with different treatment approaches in ovarian cancer.